Last edition
News about "Dr Sharvil P Patel"
FYB206 Becomes First Keytruda Biosimilar to Get US FDA Review
The US FDA has accepted FYB206’s Biologics License Application (BLA) for review, marking the first publicly announced Keytruda biosimilar filing acceptance.
Dr. Sharvil P Patel | 13/10/2026 | By News Bureau
Sentynl and Mereo Partner on Alvelestat for AATD-Associated Lung Disease
Sentynl Therapeutics and Mereo BioPharma have signed an option and license deal for alvelestat, with Sentynl set to commercialise it in the US upon option exercise.
Dr. Sharvil P Patel | 12/08/2026 | By News Bureau | 134
Zydus Lifesciences and Sunshine Healthcare Form JV to Boost Pharma Manufacturing in Sri Lanka
Zydus Lifesciences and Sunshine Healthcare launch a Joint Venture (JV) to develop a pharma manufacturing facility at BOI Horana, strengthening Sri Lanka’s supply of quality medicines.
Dr. Sharvil P Patel | 29/06/2026 | By News Bureau | 225
Zydus Launches World's First Nivolumab Biosimilar 'Tishtha' in India
Zydus Lifesciences has launched Tishtha, the world’s first biosimilar of the immunotherapy drug nivolumab, in India, aimed at expanding access to advanced cancer care by offering the treatment at nearly one-fourth the cost of the reference product for patients with multiple cancer types.
Dr Sharvil P Patel | 23/01/2026 | By News Bureau | 1267
Zydus Lifesciences Inks Exclusive Deal with Myriad Genetics for Cancer Risk Tests in India
Zydus Lifesciences has entered into an exclusive agreement with US-based Myriad Genetics to introduce clinically validated cancer-risk assessment diagnostic tests in India, aimed at enabling personalised, evidence-based cancer care and strengthening early detection and preventive oncology efforts in the country.
Dr Sharvil P Patel | 19/12/2025 | By News Bureau | 217
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy